Across TCGA patient cohorts, LINC00588 mutation is significantly associated with the RNA expression of many other genes, with 121 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible LINC00588-associated genes across cancer lineages are LYZL1, RNA5SP325, and RPL9P13. Each is linked with LINC00588 in more than 1 cancer types. Because this analysis shows association rather than direction, both LINC00588-to-partner and partner-to-LINC00588 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (LINC00588→partner) and Y-score (partner→LINC00588) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
CESC	LYZL1 →	+0.053	+5.418	<.001	.005	3	1
CESC	RNA5SP325 →	+0.378	+6.837	<.001	<.001	3	1
CESC	RPL9P13 →	+0.141	+5.010	<.001	.009	3	1
CESC	KIAA1143P2 →	+0.182	+5.812	<.001	.003	3	1
CESC	ELAVL4-AS1 →	+0.068	+5.103	<.001	.008	3	1
CESC	NPAP1P6 →	+0.018	+5.010	<.001	.009	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 121 associations by consensus.

Exploration

LINC00588 survival (RNA) · tumor vs normal (RNA) · all LINC00588 data types